212 related articles for article (PubMed ID: 32206211)
1. A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery.
Dogra P; Butner JD; Ruiz Ramírez J; Chuang YL; Noureddine A; Jeffrey Brinker C; Cristini V; Wang Z
Comput Struct Biotechnol J; 2020; 18():518-531. PubMed ID: 32206211
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Effect of Aging on the Pharmacokinetics and Tumor Delivery of Nanomaterials using Mathematical Modeling.
Dogra P; Butner JD; Ramirez JR; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():2447-2450. PubMed ID: 33018501
[TBL] [Abstract][Full Text] [Related]
3. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of Nanomedicine in Tumor Spheroid as an
Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically-Based Mathematical Model for Quantifying Nanoparticle Distribution in Tumors.
Dogra P; Chuang YL; Butner JD; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2852-2855. PubMed ID: 31946487
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput bioimaging study to assess the impact of chitosan-based nanoparticle degradation on DNA delivery performance.
Gomes CP; Varela-Moreira A; Leiro V; Lopes CDF; Moreno PMD; Gomez-Lazaro M; Pêgo AP
Acta Biomater; 2016 Dec; 46():129-140. PubMed ID: 27686038
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tumor delivery of nanoparticles.
Yuan L; Chen Q; Riviere JE; Lin Z
J Drug Deliv Sci Technol; 2023 May; 83():. PubMed ID: 38037664
[TBL] [Abstract][Full Text] [Related]
8. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
[TBL] [Abstract][Full Text] [Related]
9. Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.
Krauss M; Burghaus R; Lippert J; Niemi M; Neuvonen P; Schuppert A; Willmann S; Kuepfer L; Görlitz L
In Silico Pharmacol; 2013; 1():6. PubMed ID: 25505651
[TBL] [Abstract][Full Text] [Related]
10. The Role of
Jayasinghe MK; Lee CY; Tran TTT; Tan R; Chew SM; Yeo BZJ; Loh WX; Pirisinu M; Le MTN
Front Digit Health; 2022; 4():838590. PubMed ID: 35373184
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the in vitro nanoparticle-cell interactions via a smoothing-splines mixed-effects model.
Dogruoz E; Dayanik S; Budak G; Sabuncuoglu I
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):800-10. PubMed ID: 25962529
[TBL] [Abstract][Full Text] [Related]
12. A Multiscale Model to Identify Limiting Factors in Nanoparticle-Based miRNA Delivery for Tumor Inhibition
Dogra P; Ramirez JR; Butner JD; Pelaez MJ; Cristini V; Wang Z
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4230-4233. PubMed ID: 34892157
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.
Miller HA; Frieboes HB
Pharm Res; 2019 Nov; 36(12):185. PubMed ID: 31773287
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
15. A computational model for predicting nanoparticle accumulation in tumor vasculature.
Frieboes HB; Wu M; Lowengrub J; Decuzzi P; Cristini V
PLoS One; 2013; 8(2):e56876. PubMed ID: 23468887
[TBL] [Abstract][Full Text] [Related]
16. Interpretable XGBoost-SHAP Model Predicts Nanoparticles Delivery Efficiency Based on Tumor Genomic Mutations and Nanoparticle Properties.
Ma X; Tang Y; Wang C; Li Y; Zhang J; Luo Y; Xu Z; Wu F; Wang S
ACS Appl Bio Mater; 2023 Oct; 6(10):4326-4335. PubMed ID: 37683105
[TBL] [Abstract][Full Text] [Related]
17. Drug-loaded nanoparticles for cancer therapy: a high-throughput multicellular agent-based modeling study.
Wang Y; Bucher E; Rocha H; Jadhao V; Metzcar J; Heiland R; Frieboes HB; Macklin P
bioRxiv; 2024 Apr; ():. PubMed ID: 38645004
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles.
Xiong F; Nirupama S; Sirsi SR; Lacko A; Hoyt K
Nanotheranostics; 2017; 1(4):440-449. PubMed ID: 29188177
[TBL] [Abstract][Full Text] [Related]
19. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
20. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
